As per our current Database, Dilip Shanghvi is still alive (as per Wikipedia, Last update: May 10, 2020).
Currently, Dilip Shanghvi is 65 years, 8 months and 24 days old. Dilip Shanghvi will celebrate 66rd birthday on a Friday 1st of October 2021. Below we countdown to Dilip Shanghvi upcoming birthday.
|Popular As||Dilip Shanghvi|
|Age||65 years old|
|Born||October 01, 1955 (Amreli, Gujarat, India, India)|
|Town/City||Amreli, Gujarat, India, India|
Dilip Shanghvi’s zodiac sign is Scorpio. According to astrologers, Scorpio-born are passionate and assertive people. They are determined and decisive, and will research until they find out the truth. Scorpio is a great leader, always aware of the situation and also features prominently in resourcefulness. Scorpio is a Water sign and lives to experience and express emotions. Although emotions are very important for Scorpio, they manifest them differently than other water signs. In any case, you can be sure that the Scorpio will keep your secrets, whatever they may be.
Dilip Shanghvi was born in the Year of the Goat. Those born under the Chinese Zodiac sign of the Goat enjoy being alone in their thoughts. They’re creative, thinkers, wanderers, unorganized, high-strung and insecure, and can be anxiety-ridden. They need lots of love, support and reassurance. Appearance is important too. Compatible with Pig or Rabbit.
Our story is all about incremental growth. We"re not looking for big leaps; we prefer small jumps.
Shanghvi started Sun Pharmaceutical Industries with capital of ₹10,000 in 1982 at Vapi, with one psychiatry drug and a partner, Pradeep Ghosh. In 1997, Sun acquired Caraco Pharma, a loss-making American company, with the aim of expanding Sun's reach in the United States. Sun also acquired Israel's Taro Pharma in 2007. Shanghvi stepped down as chairman and CEO in 2012 and chose Israel Makov, formerly CEO of Teva Pharmaceuticals, as his successor; Shangvi became managing Director. In April 2014 Sun, Ranbaxy, and Daiichi Sankyo (the majority shareholder in Ranbaxy) agreed that Sun would acquire all outstanding shares of Ranbaxy for $3.2B in Sun stock and that Sun would take on $800M in Ranbaxy debt; the deal closed in March 2015 and made Sun the largest drug company in India and the fifth largest in the world, and made Daiichi the second largest shareholder in Sun.
As of August 2014, he had a net worth of $17.2 billion.